Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane on CKMB Release After PCI
NCT02671084Phase 4Terminated
- Sponsor
- Instituto Dante Pazzanese de Cardiologia
- Start
- Feb 2016
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sevoflurane in myocardial infarction (MI) (2 arms), sponsored by Instituto Dante Pazzanese de Cardiologia. Primary endpoint: Creatine Kinase-MB Level at 24 hours. Started Feb 2016; status: terminated.
02
Drugs
sevoflurane
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT02671084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02671084.